Note: Biopta (Glasgow, UK and Maryland, USA) is now REPROCELL’s Center for predictive Drug Discovery.
Note: Reinnervate (Durham, UK) is now part of REPROCELL’s Center for predictive Drug Discovery.
On the REPROCELL blog
Latest
REPROCELL Connects with Maryland Governor Moore During His Japan Visit
Maryland Governor Moore strengthens biotech ties with Japan, highlighting REPROCELL's pivotal role in the Maryland-Kanagawa partnership during his trade mission.
22 April 2025
Exosomes from Stem Cells: iPSC vs. MSC-Derived Exosomes for Aesthetic and Regenerative Medicine
Discover how iPSC and MSC-derived exosomes revolutionize skin rejuvenation and anti-aging treatments in aesthetic medicine. Main Point Summary: The blog explores the potential of exosomes derived from induced pluripotent stem cells (iPSCs) and mesenchymal stem cells (MSCs) for skin rejuvenation and anti-aging treatments in aesthetic medicine, comparing their effectiveness, mechanisms, and applications.
14 April 2025
Can Stem Cells Revolutionize Sustainable Food Production?
Discover how stem cell technology is transforming sustainable food production, offering ethical and scalable alternatives to conventional meat, dairy, and seafood.
31 March 2025
Advancing Clinical Research Through Patient Engagement: The Impact of Tissue Biopsy Donation
Discover how patient engagement and tissue biopsy donation are revolutionizing clinical research, enhancing personalized medicine, and fostering deeper collaboration between researchers and patients.
19 March 2025
Qkineʼs Animal-Free Growth Factors and Cytokines are ideal for Stem Cell Culture
Qkine's growth factors and cytokines are of exceptional bioactivity and purity - essential for maintaining and differentiating stem cell cultures.
07 March 2025
.jpg?width=800&height=450&name=Biopta%20(Scottish%20Life%20Sciences).jpg)
